1. Home
  2. WVE vs ARRY Comparison

WVE vs ARRY Comparison

Compare WVE & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$3.37

Market Cap

673.9M

Sector

Health Care

ML Signal

N/A

Logo Array Technologies Inc.

ARRY

Array Technologies Inc.

N/A

Current Price

$5.84

Market Cap

548.3M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
ARRY
Founded
2012
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
673.9M
548.3M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
WVE
ARRY
Price
$3.37
$5.84
Analyst Decision
Strong Buy
Buy
Analyst Count
21
24
Target Price
★ $17.05
$6.94
AVG Volume (30 Days)
2.9M
★ 9.7M
Earning Date
10-27-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 62.56
EPS
N/A
★ N/A
Revenue
$3,704,000.00
★ $1,284,141,000.00
Revenue This Year
$48.79
$12.03
Revenue Next Year
N/A
$13.37
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 149.43
40.22
52 Week Low
$3.04
$3.09
52 Week High
$21.73
$12.23

Technical Indicators

Market Signals
Indicator
WVE
ARRY
Relative Strength Index (RSI) 43.99 78.33
Support Level $3.04 $4.77
Resistance Level $3.97 $6.34
Average True Range (ATR) 0.24 0.37
MACD 0.05 0.30
Stochastic Oscillator 35.14 92.21

Price Performance

Historical Comparison
WVE
ARRY

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes, and electronic controllers referred to as a single-axis tracker that moves solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil, and the rest of the world, with the United States deriving the majority of the revenue.

Share on Social Networks: